Companies like Turing Pharmaceuticals and KV Pharmaceuticals have grabbed headlines recently for their aggressive pricing strategies. Whether these strategies are justified or even successful is not the point. Rather, what is important is the negative public  perception that significant price hikes create for the industry as a whole.

In this climate, the industry needs to do a better job of talking about how prices are set and how that money is invested—otherwise we risk losing control of how we
price our products and operate our businesses.

 

 

Author:

Jonathan Hodgson

[Download White Paper]